Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype

Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype

Thumbnail Image
Download
Name

Connor-2015-Physical nanoscale.pdf

Size

4.06 MB

Format

Adobe PDF

Checksum (MD5)

5027a1ef1bdca75f859d148a042dbc5e

Author(s)
Connor, Yamicia
•
Tekleab, Sarah
•
Nandakumar, Shyama
•
Walls, Cherelle
•
Tekleab, Yonatan
•
Husain, Amjad
•
Gadish, Or
•
Sabbisetti, Venkata
•
Kaushik, Shelly
•
Sehrawat, Seema
more
Date Issued
December 2015
Journal
Nature Communications
Publisher
Nature Publishing Group
Citation
Connor, Yamicia, Sarah Tekleab, Shyama Nandakumar, Cherelle Walls, Yonatan Tekleab, Amjad Husain, Or Gadish, et al. “Physical Nanoscale Conduit-Mediated Communication Between Tumour Cells and the Endothelium Modulates Endothelial Phenotype.” Nat Comms 6 (December 16, 2015): 8671. © 2015 Macmillan Publishers Limited
Version
Final published version
Abstract
Metastasis is a major cause of mortality and remains a hurdle in the search for a cure for cancer. Not much is known about metastatic cancer cells and endothelial cross-talk, which occurs at multiple stages during metastasis. Here we report a dynamic regulation of the endothelium by cancer cells through the formation of nanoscale intercellular membrane bridges, which act as physical conduits for transfer of microRNAs. The communication between the tumour cell and the endothelium upregulates markers associated with pathological endothelium, which is reversed by pharmacological inhibition of these nanoscale conduits. These results lead us to define the notion of ‘metastatic hijack’: cancer cell-induced transformation of healthy endothelium into pathological endothelium via horizontal communication through the nanoscale conduits. Pharmacological perturbation of these nanoscale membrane bridges decreases metastatic foci in vivo. Targeting these nanoscale membrane bridges may potentially emerge as a new therapeutic opportunity in the management of metastatic cancer.
MIT Department
Harvard University--MIT Division of Health Sciences and Technology
Massachusetts Institute of Technology. Department of Aeronautics and Astronautics
Terms of Use
Creative Commons Attribution
http://creativecommons.org/licenses/by/4.0/
Persistent DSpace Link
http://hdl.handle.net/1721.1/100898
DOI of Published Version
https://doi.org/10.1038/ncomms9671
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.